Baofeng Lian

1.4k total citations
27 papers, 837 citations indexed

About

Baofeng Lian is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Baofeng Lian has authored 27 papers receiving a total of 837 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 11 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Baofeng Lian's work include Bioinformatics and Genomic Networks (9 papers), MicroRNA in disease regulation (7 papers) and Ferroptosis and cancer prognosis (6 papers). Baofeng Lian is often cited by papers focused on Bioinformatics and Genomic Networks (9 papers), MicroRNA in disease regulation (7 papers) and Ferroptosis and cancer prognosis (6 papers). Baofeng Lian collaborates with scholars based in China, United States and Germany. Baofeng Lian's co-authors include Lu Xie, Wei Jiang, Xia Li, Xiaowen Chen, Lun–Xiu Qin, Qiongzhu Dong, Fanlin Meng, Shuyuan Wang, Wěi Li and Wei Li and has published in prestigious journals such as Journal of Clinical Oncology, Bioinformatics and PLoS ONE.

In The Last Decade

Baofeng Lian

26 papers receiving 827 citations

Peers

Baofeng Lian
Hoi-Wing Leung Hong Kong
Lit‐Hsin Loo Singapore
Aritro Nath United States
Jaegyoon Ahn South Korea
Pedro Casado United Kingdom
Marjo de Graauw Netherlands
Hoi-Wing Leung Hong Kong
Baofeng Lian
Citations per year, relative to Baofeng Lian Baofeng Lian (= 1×) peers Hoi-Wing Leung

Countries citing papers authored by Baofeng Lian

Since Specialization
Citations

This map shows the geographic impact of Baofeng Lian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baofeng Lian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baofeng Lian more than expected).

Fields of papers citing papers by Baofeng Lian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Baofeng Lian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baofeng Lian. The network helps show where Baofeng Lian may publish in the future.

Co-authorship network of co-authors of Baofeng Lian

This figure shows the co-authorship network connecting the top 25 collaborators of Baofeng Lian. A scholar is included among the top collaborators of Baofeng Lian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Baofeng Lian. Baofeng Lian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Yan, et al.. (2025). Mechanism and role of regulated cell death in tumor immunity and immunotherapy. Cancer Communications. 45(11). 1456–1495.
2.
Liu, Dongli, Lili Lu, Lili Dong, et al.. (2020). miR-17-5p and miR-20a-5p suppress postoperative metastasis of hepatocellular carcinoma via blocking HGF/ERBB3-NF-κB positive feedback loop. Theranostics. 10(8). 3668–3683. 40 indexed citations
3.
Wang, Gang, Jian Ouyang, Li Shen, et al.. (2019). The analysis of risk factors for diabetic nephropathy progression and the construction of a prognostic database for chronic kidney diseases. Journal of Translational Medicine. 17(1). 264–264. 67 indexed citations
4.
Liu, Zhenhao, Baofeng Lian, Qiongzhu Dong, et al.. (2018). Whole-exome mutational and transcriptional landscapes of combined hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma reveal molecular diversity. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(6). 2360–2368. 53 indexed citations
5.
Li, Xiangyi, Yingjie Xu, Hui Cui, et al.. (2017). Prediction of synergistic anti-cancer drug combinations based on drug target network and drug induced gene expression profiles. Artificial Intelligence in Medicine. 83. 35–43. 82 indexed citations
6.
Ouyang, Jian, Wei Li, Wen Zhang, et al.. (2016). dbPHCC: a database of prognostic biomarkers for hepatocellular carcinoma that provides online prognostic modeling. Biochimica et Biophysica Acta (BBA) - General Subjects. 1860(11). 2688–2695. 6 indexed citations
7.
Ye, Qing‐Hai, Wenwei Zhu, Jubo Zhang, et al.. (2016). GOLM1 Modulates EGFR/RTK Cell-Surface Recycling to Drive Hepatocellular Carcinoma Metastasis. Cancer Cell. 30(3). 444–458. 178 indexed citations
8.
Li, Wei, Jian Yu, Baofeng Lian, et al.. (2015). Identifying Prognostic Features by Bottom-Up Approach and Correlating to Drug Repositioning. PLoS ONE. 10(3). e0118672–e0118672. 11 indexed citations
9.
Wang, Shuyuan, Wei Li, Baofeng Lian, et al.. (2015). TMREC: A Database of Transcription Factor and MiRNA Regulatory Cascades in Human Diseases. PLoS ONE. 10(5). e0125222–e0125222. 19 indexed citations
10.
Chen, Xiaowen, Yanqiu Wang, Pingping Wang, et al.. (2015). Systematic Analysis of the Associations between Adverse Drug Reactions and Pathways. BioMed Research International. 2015. 1–12. 10 indexed citations
11.
Yu, Xuexin, Baofeng Lian, Lihong Wang, et al.. (2014). The pan-cancer analysis of gene expression patterns in the context of inflammation. Molecular BioSystems. 10(9). 2270–2276. 9 indexed citations
12.
Zhang, Yuannv, Zhaoping Qiu, Lin Wei, et al.. (2014). Integrated Analysis of Mutation Data from Various Sources Identifies Key Genes and Signaling Pathways in Hepatocellular Carcinoma. PLoS ONE. 9(7). e100854–e100854. 33 indexed citations
13.
Li, Ling, Baofeng Lian, Chao Li, et al.. (2014). Integrative Analysis of Transcriptional Regulatory Network and Copy Number Variation in Intrahepatic Cholangiocarcinoma. PLoS ONE. 9(6). e98653–e98653. 6 indexed citations
14.
Cheng, Shangli, Baofeng Lian, Juan Liang, et al.. (2013). Site selectivity for protein tyrosine nitration: insights from features of structure and topological network. Molecular BioSystems. 9(11). 2860–2868. 9 indexed citations
15.
Huang, Tao, Jian Yu, Lingyao Zeng, et al.. (2013). Comparative analysis of viral protein interaction networks in Hepatitis B Virus and Hepatitis C Virus infected HCC. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1844(1). 271–279. 8 indexed citations
16.
Jiang, Wei, Xiaowen Chen, Mingzhi Liao, et al.. (2012). Identification of links between small molecules and miRNAs in human cancers based on transcriptional responses. Scientific Reports. 2(1). 282–282. 68 indexed citations
17.
Wang, Yanqiu, Xiaowen Chen, Wei Jiang, et al.. (2011). Predicting human microRNA precursors based on an optimized feature subset generated by GA–SVM. Genomics. 98(2). 73–78. 54 indexed citations
18.
Li, Xin, Wei Jiang, Wei Li, et al.. (2011). Dissection of human MiRNA regulatory influence to subpathway. Briefings in Bioinformatics. 13(2). 175–186. 27 indexed citations
19.
Liao, Mingzhi, Wei Jiang, Xiaowen Chen, et al.. (2010). Systematic analysis of regulation and functions of co-expressed microRNAs in humans. Molecular BioSystems. 6(10). 1863–1872. 2 indexed citations
20.
Jiang, Wei, Wěi Li, Baofeng Lian, et al.. (2010). Topological properties of the drug targets regulated by microRNA in human protein–protein interaction network. Journal of drug targeting. 19(5). 354–364. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026